You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Article metrics

Article menu

Download PDFPDF

Research Article
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019220
Jan 2020552
Feb 202010101
Mar 202017172
Apr 2020882
May 202020204
Jun 202017173
Jul 202010102
Aug 2020991
Sep 202019190
Oct 202021212
Nov 202017171
Dec 202012124
Jan 2021652
Feb 202118185
Mar 202112127
Apr 202114143
May 202111116
Jun 202120201
Jul 202116167
Aug 202126265
Sep 202118181
Oct 202118188
Nov 202110105
Dec 202122228
Jan 2022303410
Feb 202225299
Mar 202235387
Apr 202221235
May 2022353611
Jun 202238439
Jul 202229305
Aug 202248486
Sep 202236429
Oct 202236388
Nov 2022343922
Dec 202212124
Jan 202329294
Feb 202346474
Mar 202330308
Apr 202328293
May 2023131312
Jun 202315155
Jul 202325263
Aug 202325254
Sep 202321213
Oct 20231461469
Nov 20233903909
Dec 2023133135105
Jan 2024434893
Feb 2024232315
Mar 2024353522
Apr 2024292915
May 2024222310
Jun 202417177
Jul 2024434410
Aug 202424248
Sep 2024212513
Oct 2024262611
Nov 202416177
Dec 2024626311
Jan 2025414424
Feb 202523238
Mar 2025292911
Apr 2025374321
May 2025383816
Jun 2025444516
Total22112271674